Jci_page_head_homepage_01 Jci_page_head_homepage_02
Annemiek D. Tepper, Evert de Vries, Wim J. van Blitterswijk, Jannie Borst
Published in Volume 103, Issue 7
J Clin Invest. 1999; 103(7):971–978 doi:10.1172/JCI5457
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 7

Mapping the Cer response in relation to caspase activation and mitochondrial changes in the CD95, etoposide, and IR pathways in Jurkat cells. Cer is placed in between initiator and executioner caspases in all cases, because its accumulation is inhibited by zVAD-fmk but not by DEVD-CHO. CD95 requires casp-8, whereas DNA damage–induced Cer formation does not involve casp-8 or death receptor signaling. In the case of etoposide or IR, the most proximal zVAD-fmk target resides at, or downstream from, the mitochondria, since zVAD-fmk does not block cyt c release. Bcl-2 overexpression abrogates Cer formation in response to etoposide or IR but only partially interferes with the CD95-induced Cer response. Possible roles of Cer are indicated by dotted lines. DEVD-CHO, acetyl-DEVD-aldehyde.